| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.1M | +7333.2% |
| Cost of Revenue | $1.8M | +109.0% |
| Gross Profit | $8.3M | — |
| R&D Expense | $9.2M | — |
| SG&A Expense | $16.1M | +5855.2% |
| Interest Expense | $621K | — |
| Pre-tax Income | -$24.7M | -9372.1% |
| Income Tax | $434K | — |
| Net Income | -$25.1M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | — |
| Inventory | $2.1M | — |
| Current Assets | $24.0M | — |
| Total Assets | $42.6M | — |
| Current Liabilities | $22.7M | +3327.4% |
| Total Liabilities | $22.8M | +3298.8% |
| Stockholders' Equity | $19.7M | +3181.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | -3980.5% |
| Capital Expenditures | $5K | -97.7% |
| Investing Cash Flow | -$2.0M | — |
| Financing Cash Flow | $7.2M | +7603.7% |
| Free Cash Flow | -$4.9M | -1301.4% |
| EPS (Basic) | -$0.07 | — |
| EPS (Diluted) | -$0.07 | — |